Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

MediciNova reports positive results from SPRINT-MS trial

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Credit: Cleveland Clinic MD Robert J Fox / NIH…Turning Discovery Into Health.



Go Top